Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer

  Free Subscription


Articles published in Int J Gynecol Cancer

Retrieve available abstracts of 151 articles:
HTML format



Single Articles


    November 2022
  1. DZINAMARIRA T, Moyo E, Dzobo M, Mbunge E, et al
    Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
    Int J Gynecol Cancer. 2022 Nov 11. pii: ijgc-2022-003957.
    PubMed     Abstract available


  2. OYMAK E, Guler OC, Onal C
    Prognostic significance of albumin and globulin levels in cervical cancer patients treated with chemoradiotherapy.
    Int J Gynecol Cancer. 2022 Nov 10. pii: ijgc-2022-003768.
    PubMed     Abstract available


  3. SALVO G, Ramalingam P, Bhosale P, Frumovitz M, et al
    Advanced stage (FIGO IVB) neuroendocrine cervical carcinoma.
    Int J Gynecol Cancer. 2022;32:1469-1474.
    PubMed    


  4. SELCUK I
    Correspondence on 'Simplified anatomical nomenclature of lateral female pelvic spaces' by Querleu et al.
    Int J Gynecol Cancer. 2022;32:1495.
    PubMed    


  5. CHIVA L, Gonzalez-Rodriguez M, Tendobi C
    Locally advanced vulvar carcinoma diagnosed during cervical cancer screening.
    Int J Gynecol Cancer. 2022;32:1492.
    PubMed    


  6. DOMINGO S, Balasubbaiah Y, Nyndala S, Garcia I, et al
    Surgical training and cervical screening in rural India hospitals.
    Int J Gynecol Cancer. 2022;32:1475-1476.
    PubMed    


    October 2022
  7. DATTA GD, Mayrand MH, Glenn BA
    Correspondence on "The increasing incidence of stage IV cervical cancer in the USA: what factors are related?" by Francoeur et al.
    Int J Gynecol Cancer. 2022 Oct 28. pii: ijgc-2022-004066.
    PubMed    


  8. MONK BJ, Tan DSP, Hernandez Chagui JD, Takyar J, et al
    Proportions and incidence of locally advanced cervical cancer: a global systematic literature review.
    Int J Gynecol Cancer. 2022 Oct 14. pii: ijgc-2022-003801.
    PubMed     Abstract available


  9. GAO H, Wu H, Zhang Y, Chen Z, et al
    Locoregional therapy for oligometastatic cervical cancer: a single-center retrospective study.
    Int J Gynecol Cancer. 2022 Oct 13. pii: ijgc-2022-003620.
    PubMed     Abstract available


  10. TON M, Swami N, Germar MJV, Dee EC, et al
    HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries.
    Int J Gynecol Cancer. 2022 Oct 11. pii: ijgc-2022-003959.
    PubMed    


  11. KOTHA NV, Williamson CW, Marra KV, McHale M, et al
    Incomplete cisplatin regimens in chemoradiation and its effect on outcomes for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2022 Oct 6. pii: ijgc-2022-003766.
    PubMed     Abstract available


  12. ROY M, Finch L, Kwon D, Jordan SE, et al
    Factors contributing to delays in initiation of front-line cervical cancer therapy: disparities in a diverse south Florida population.
    Int J Gynecol Cancer. 2022 Oct 5. pii: ijgc-2022-003475.
    PubMed     Abstract available


    September 2022
  13. CALO C, Barrington DA, Mclaughlin EM, Bixel K, et al
    Help wanted: low provider density is associated with advanced stage cervical cancer.
    Int J Gynecol Cancer. 2022 Sep 28. pii: ijgc-2022-003779.
    PubMed     Abstract available


  14. CAPISTRANO I R, Paul S, Boere I, Pantziarka P, et al
    Drug repurposing as a potential source of innovative therapies in cervical cancer.
    Int J Gynecol Cancer. 2022 Sep 22. pii: ijgc-2022-003585.
    PubMed     Abstract available


  15. MARTINEZ A, Diaz-Feijoo B, Querleu D
    Para-aortic lymphadenectomy in cervical cancer deserves a new trial.
    Int J Gynecol Cancer. 2022 Sep 16. pii: ijgc-2022-003910.
    PubMed    


  16. CIBULA D, Borcinova M, Kocian R, Feltl D, et al
    CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16).
    Int J Gynecol Cancer. 2022 Sep 13. pii: ijgc-2022-003918.
    PubMed     Abstract available


  17. CIBULA D
    Early-stage intermediate-risk-the group with the most heterogenous management among patients with cervical cancer.
    Int J Gynecol Cancer. 2022 Sep 13. pii: ijgc-2022-003908.
    PubMed    


    August 2022
  18. GLICKMAN A, Diaz-Feijoo B, Agusti N, Carreras-Dieguez N, et al
    Laparoscopically assisted radical vaginal hysterectomy in early-stage cervical cancer.
    Int J Gynecol Cancer. 2022 Aug 22. pii: ijgc-2022-003670.
    PubMed    


  19. FRANCOEUR AA, Liao CI, Casear MA, Chan A, et al
    The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
    Int J Gynecol Cancer. 2022 Aug 18. pii: ijgc-2022-003728.
    PubMed     Abstract available


  20. NOBREGA L, Zanon JR, Andrade CEEMDC, Schmidt RL, et al
    Prognostic role of hydronephrosis in the treatment of patients with locally advanced cervical cancer: a retrospective cohort.
    Int J Gynecol Cancer. 2022 Aug 16. pii: ijgc-2022-003679.
    PubMed     Abstract available


    July 2022
  21. TENDOBI C, Fernandez-Marques M, Carlos S, Amann M, et al
    Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in Kinshasa, Democratic Republic of Congo.
    Int J Gynecol Cancer. 2022 Jul 20. pii: ijgc-2022-003592.
    PubMed     Abstract available


  22. HUEPENBECKER S, Santia MC, Harrison R, Dos Reis R, et al
    Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer.
    Int J Gynecol Cancer. 2022 Jul 8. pii: ijgc-2022-003654.
    PubMed     Abstract available


  23. NASIOUDIS D, Rush M, Taunk NK, Ko EM, et al
    Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation.
    Int J Gynecol Cancer. 2022;32:823-827.
    PubMed     Abstract available


  24. PAREJA R
    Surgical staging for locally-advanced cervical cancer: the answer remains 'NO'.
    Int J Gynecol Cancer. 2022;32:828-829.
    PubMed    


  25. TOWNER M, Kim JJ, Simon MA, Matei D, et al
    Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States.
    Int J Gynecol Cancer. 2022;32:931-938.
    PubMed     Abstract available


    June 2022
  26. PFAENDLER KS, Williams HJ
    Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy.
    Int J Gynecol Cancer. 2022;32:815-816.
    PubMed    


  27. WAGNER A, Skof AS, Sehouli J, Richter R, et al
    Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
    Int J Gynecol Cancer. 2022;32:716-723.
    PubMed     Abstract available


  28. CHIKAZAWA K, Imai K, Kuwata T, Konno R, et al
    Importance of conization and pathological status.
    Int J Gynecol Cancer. 2022;32:820.
    PubMed    


    May 2022
  29. SANSON C, Zaccarini F, Majer M, Pautier P, et al
    Neoadjuvant chemotherapy in fertility-sparing management of FIGO 2018 stage IB2 cervical cancer.
    Int J Gynecol Cancer. 2022;32:680-685.
    PubMed    


    April 2022
  30. OLTHOF EP, Wenzel H, van der Velden J, Spijkerboer AM, et al
    Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking.
    Int J Gynecol Cancer. 2022 Apr 28. pii: ijgc-2022-003357.
    PubMed     Abstract available


  31. GARCIA-DURAN C, Grau F, Villacampa G, Oaknin A, et al
    ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation.
    Int J Gynecol Cancer. 2022 Apr 20. pii: ijgc-2022-003370.
    PubMed     Abstract available


  32. KOTHA NV, Williamson CW, Mell LK, Murphy JD, et al
    Disparities in time to start of definitive radiation treatment for patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2022 Apr 15. pii: ijgc-2021-003305.
    PubMed     Abstract available


  33. TOBONI MD, Cohen A, Gentry ZL, Ostby SA, et al
    Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.
    Int J Gynecol Cancer. 2022 Apr 15. pii: ijgc-2021-003227.
    PubMed     Abstract available



  34. Correction: Human papillomavirus-independent cervical cancer: what are the implications?
    Int J Gynecol Cancer. 2022;32:582.
    PubMed    


  35. GLENNON K, Treacy A, Geoghegan T, Downey P, et al
    Endocervical adenocarcinoma in situ with ovarian metastases.
    Int J Gynecol Cancer. 2022;32:566-569.
    PubMed    


  36. ANGELES MA, Bizzarri N, Shushkevich A, Gomez-Hidalgo NR, et al
    Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilation.
    Int J Gynecol Cancer. 2022;32:468-473.
    PubMed    


  37. AGUSTI N, Zorrilla Vaca A, Segarra-Vidal B, Iniesta MD, et al
    Outcomes of open radical hysterectomy following implementation of an enhanced recovery after surgery program.
    Int J Gynecol Cancer. 2022;32:480-485.
    PubMed     Abstract available


    March 2022
  38. LEE J, Lin JB, Chang CL, Jan YT, et al
    Optimal prophylactic para-aortic radiotherapy in locally advanced cervical cancer: anatomy-based versus margin-based delineation.
    Int J Gynecol Cancer. 2022 Mar 30. pii: ijgc-2021-003298.
    PubMed     Abstract available


  39. LI D, Huang S, Liu K, Qin Y, et al
    Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis.
    Int J Gynecol Cancer. 2022 Mar 24. pii: ijgc-2021-003159.
    PubMed     Abstract available


  40. GRACE L, Sanday K, Garrett A, Land R, et al
    Vaginal vault smear cytology in detection of recurrence after hysterectomy for early cervical cancer.
    Int J Gynecol Cancer. 2022 Mar 14. pii: ijgc-2021-003302.
    PubMed     Abstract available


  41. MAYADEV JS, Ke G, Mahantshetty U, Pereira MD, et al
    Global challenges of radiotherapy for the treatment of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2022;32:436-445.
    PubMed     Abstract available


  42. SHERER MV, Kotha NV, Williamson C, Mayadev J, et al
    Advances in immunotherapy for cervical cancer: recent developments and future directions.
    Int J Gynecol Cancer. 2022;32:281-287.
    PubMed     Abstract available


  43. STURDZA AE, Knoth J
    Image-guided brachytherapy in cervical cancer including fractionation.
    Int J Gynecol Cancer. 2022;32:273-280.
    PubMed     Abstract available


  44. MIRIYALA R, Mahantshetty U, Maheshwari A, Gupta S, et al
    Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future.
    Int J Gynecol Cancer. 2022;32:260-265.
    PubMed     Abstract available


  45. TSENG M, Ngoi NY, Tan DS, Tong PS, et al
    Combined modality management of advanced cervical cancer including novel sensitizers.
    Int J Gynecol Cancer. 2022;32:246-259.
    PubMed     Abstract available


  46. PINTO PJJ, Chen MJ, Santos Neto E, Faloppa CC, et al
    Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis.
    Int J Gynecol Cancer. 2022;32:239-245.
    PubMed     Abstract available


  47. CHOU B, Prasad Venkatesulu B, Coleman RL, Harkenrider M, et al
    Management of stage I and II cervical cancer: a review.
    Int J Gynecol Cancer. 2022;32:216-224.
    PubMed     Abstract available


  48. FENLON JB, Rositch AF, Dickey BL, Kimani S, et al
    Gynecological radiotherapy in people living with human immunodeficiency virus: a semi-systematic literature review.
    Int J Gynecol Cancer. 2022;32:429-435.
    PubMed     Abstract available


  49. BHATIA R, Lichter KE, Gurram L, MacDuffie E, et al
    The state of gynecologic radiation therapy in low- and middle-income countries.
    Int J Gynecol Cancer. 2022;32:421-428.
    PubMed     Abstract available


  50. ZHOU Y, Espenel S, Achkar S, Leary A, et al
    Combined modality including novel sensitizers in gynecological cancers.
    Int J Gynecol Cancer. 2022;32:389-401.
    PubMed     Abstract available


  51. DONOVAN EK, Covens AL, Kupets RS, Leung EW, et al
    The role of oophoropexy in patients with gynecological cancer who need radiation therapy.
    Int J Gynecol Cancer. 2022;32:380-388.
    PubMed     Abstract available


  52. KIDD EA
    Imaging to optimize gynecological radiation oncology.
    Int J Gynecol Cancer. 2022;32:358-365.
    PubMed     Abstract available


  53. JHINGRAN A
    Updates in the treatment of vaginal cancer.
    Int J Gynecol Cancer. 2022;32:344-351.
    PubMed     Abstract available


  54. HSU IC, Yoshida E
    Ultrasound guidance for cervical implantation.
    Int J Gynecol Cancer. 2022;32:266-272.
    PubMed     Abstract available


  55. FRANCO I, Viswanathan AN
    Radiation oncology management of stage III and IVA cervical carcinoma.
    Int J Gynecol Cancer. 2022;32:231-238.
    PubMed     Abstract available


  56. CHOPRA S, Ranjan N, Mittal P
    Postoperative adjuvant radiation for cervix cancer: reflections on the evidence and a peep into the future.
    Int J Gynecol Cancer. 2022;32:225-230.
    PubMed     Abstract available


    February 2022
  57. VIVEROS-CARRENO D, Rodriguez J, Rendon Pereira GJ, Slama J, et al
    Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.
    Int J Gynecol Cancer. 2022 Feb 24. pii: ijgc-2021-003297.
    PubMed     Abstract available


  58. MACCHIA G, Nardangeli A, Laliscia C, Fodor A, et al
    Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
    Int J Gynecol Cancer. 2022 Feb 22. pii: ijgc-2021-003237.
    PubMed     Abstract available


  59. REGAUER S, Reich O, Kashofer K
    Correspondence on "Human papillomavirus-independent cervical cancer" by Fernandes et al.
    Int J Gynecol Cancer. 2022 Feb 15. pii: ijgc-2022-003368.
    PubMed    


  60. TONINI F, Michel D, Foulon A
    An unusual cause of cervical bleeding.
    Int J Gynecol Cancer. 2022;32:214.
    PubMed    


  61. CHACON E, Manzour N, Zanagnolo V, Querleu D, et al
    SUCCOR cone study: conization before radical hysterectomy.
    Int J Gynecol Cancer. 2022;32:117-124.
    PubMed     Abstract available


  62. NASIOUDIS D, Ramirez PT
    Is prior conization the way forward to determine surgical approach? The answer is not so simple!
    Int J Gynecol Cancer. 2022;32:125-126.
    PubMed    


  63. SERRA RUBERT A, Climent MT, Llueca Abella A
    Schauta, an old technique for a new discussion.
    Int J Gynecol Cancer. 2022;32:205-206.
    PubMed    


    January 2022
  64. ILHAN Y, Tatli AM, Teker F, Onder AH, et al
    Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.
    Int J Gynecol Cancer. 2022 Jan 27. pii: ijgc-2021-003165.
    PubMed     Abstract available


  65. DREYER G, Botha MH, Snyman LC, Visser C, et al
    Combining cervical cancer screening for mothers with schoolgirl vaccination during human papillomavirus (HPV) vaccine implementation in South Africa: results from the VACCS1 and VACCS2 trials.
    Int J Gynecol Cancer. 2022 Jan 25. pii: ijgc-2021-003079.
    PubMed     Abstract available


  66. IJFF M, Crezee J, Oei AL, Stalpers LJA, et al
    The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review.
    Int J Gynecol Cancer. 2022 Jan 19. pii: ijgc-2021-002473.
    PubMed     Abstract available


  67. BIZZARRI N, Pletnev A, Razumova Z, Zalewski K, et al
    Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO).
    Int J Gynecol Cancer. 2022 Jan 6. pii: ijgc-2021-002812.
    PubMed     Abstract available


  68. PEREZ MONTIEL CA, Varela Aguirre GJ
    Primary non-gestational choriocarcinoma of the uterine cervix.
    Int J Gynecol Cancer. 2022;32:111-112.
    PubMed    


  69. GORDHANDAS SB, Kahn R, Sassine D, Aviki EM, et al
    Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines.
    Int J Gynecol Cancer. 2022;32:79-88.
    PubMed     Abstract available


  70. DAIX M, Angeles MA, Leray H, Vergriete K, et al
    Anterior pelvic exenteration and laterally extended pelvic resection: a step by step procedure.
    Int J Gynecol Cancer. 2022;32:107-108.
    PubMed    


  71. DEVAJA O, Papadopoulos AJ, Bharathan R, Montalto SA, et al
    Sentinel lymph node biopsy alone in the management of early cervical carcinoma.
    Int J Gynecol Cancer. 2022;32:15-20.
    PubMed     Abstract available


    December 2021
  72. RODRIGUES AN, de Melo AC, Calabrich AFC, Cronenberger E, et al
    Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215).
    Int J Gynecol Cancer. 2021 Dec 29. pii: ijgc-2021-002972.
    PubMed     Abstract available


  73. DARIN MC, Di Guilmi J, Quiroga Luna J, Maya AG, et al
    Cervical cancer after LACC: a combination of surgical strategies.
    Int J Gynecol Cancer. 2021 Dec 16. pii: ijgc-2021-003042.
    PubMed    


  74. BOHN JA, Hernandez-Zepeda ML, Hersh AR, Munro EG, et al
    Does obesity influence the preferred treatment approach for early-stage cervical cancer? A cost-effectiveness analysis.
    Int J Gynecol Cancer. 2021 Dec 9. pii: ijgc-2021-003004.
    PubMed     Abstract available



  75. Correction: Cervical cancer in pregnancy at various gestational ages.
    Int J Gynecol Cancer. 2021;31:1624.
    PubMed    


    November 2021
  76. SCHMELER KM, Batman SH
    Human papillomavirus-independent cervical cancer: what are the implications?
    Int J Gynecol Cancer. 2021 Nov 29. pii: ijgc-2021-003250.
    PubMed    


  77. POUYEZ C, Dami M
    Gallstone mimicking metastatic cervical cancer.
    Int J Gynecol Cancer. 2021;31:1496.
    PubMed    


  78. FERNANDES A, Viveros-Carreno D, Hoegl J, Avila M, et al
    Human papillomavirus-independent cervical cancer.
    Int J Gynecol Cancer. 2021 Nov 1. pii: ijgc-2021-003014.
    PubMed     Abstract available


  79. HARRY V, Persad S, Barrow T, Rattan R, et al
    UK-trained specialists perform first radical trachelectomy in Trinidad and Tobago.
    Int J Gynecol Cancer. 2021;31:1486-1487.
    PubMed    


    October 2021
  80. LI J, Gu C, Zheng H, Geng X, et al
    Ultrasonographic diagnosis in rare primary cervical cancer.
    Int J Gynecol Cancer. 2021 Oct 28. pii: ijgc-2021-002860.
    PubMed     Abstract available


  81. VIVEROS-CARRENO D, Rodriguez J, Pareja R
    Incidence of metastasis in circumflex iliac nodes in patients with cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2021 Oct 7. pii: ijgc-2021-003005.
    PubMed     Abstract available



  82. Correction: Infection versus cancer: management of actinomyces mimicking cervical cancer or ovarian cancer.
    Int J Gynecol Cancer. 2021;31:1400.
    PubMed    


  83. SOZZI G, Chiantera V
    Vena cava resection and bypass for recurrent cervical cancer.
    Int J Gynecol Cancer. 2021;31:1393.
    PubMed    


  84. ODETTO D, Saadi JM, Chacon CB, Wernicke A, et al
    Uterine transposition after radical trachelectomy.
    Int J Gynecol Cancer. 2021;31:1374-1379.
    PubMed    


  85. LERAY H, Angeles MA, Daix M, Martinez A, et al
    How to avoid peritoneal tumor spillage during total abdominal hysterectomy in uterine cancers with cervical invasion.
    Int J Gynecol Cancer. 2021;31:1382-1383.
    PubMed    


    September 2021
  86. DATTA A, West C, O'Connor JPB, Choudhury A, et al
    Impact of hypoxia on cervical cancer outcomes.
    Int J Gynecol Cancer. 2021 Sep 30. pii: ijgc-2021-002806.
    PubMed     Abstract available


  87. ABU-RUSTUM NR
    ConCerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer, by Schmeler et al.
    Int J Gynecol Cancer. 2021 Sep 24. pii: ijgc-2021-003008.
    PubMed    


  88. SCHMELER KM, Pareja R, Lopez Blanco A, Humberto Fregnani J, et al
    ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.
    Int J Gynecol Cancer. 2021 Sep 7. pii: ijgc-2021-002921.
    PubMed     Abstract available


    August 2021
  89. LUVIAN-MORALES J, Flores-Cisneros L, Jimenez-Lima R, Alarcon-Barrios S, et al
    Validation of the QLQ-CX24 questionnaire for the assessment of quality of life in Mexican women with cervical cancer.
    Int J Gynecol Cancer. 2021 Aug 5. pii: ijgc-2021-002720.
    PubMed     Abstract available


  90. SALVO G, Ramalingam P, Bhosale P, Frumovitz M, et al
    Early-stage, high-grade neuroendocrine cervical carcinoma.
    Int J Gynecol Cancer. 2021;31:1179-1183.
    PubMed    


  91. NASIOUDIS D, Byrne M, Ko EM, Haggerty AF, et al
    Minimally invasive hysterectomy for stage IA cervical carcinoma: a survival analysis of the National Cancer Database.
    Int J Gynecol Cancer. 2021;31:1099-1103.
    PubMed     Abstract available


    July 2021
  92. BORIA F, Chiva L, Zanagnolo V, Querleu D, et al
    Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators.
    Int J Gynecol Cancer. 2021 Jul 28. pii: ijgc-2021-002587.
    PubMed     Abstract available


  93. GROVER S, Ning MS, Bale M, Lichter KE, et al
    Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
    Int J Gynecol Cancer. 2021 Jul 26. pii: ijgc-2021-002601.
    PubMed     Abstract available


  94. SPENCER NM, Bos L
    Intracardiac metastatic cervical cancer.
    Int J Gynecol Cancer. 2021;31:1095.
    PubMed    


  95. NASIOUDIS D, Albright BB, Ko EM, Haggerty AF, et al
    Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2021;31:983-990.
    PubMed     Abstract available


    June 2021
  96. CHILINDA G, Massamba L, Meja S, Ngo C, et al
    Implementing a comprehensive cervical cancer program in Southern Malawi: a 'Medecins Sans Frontieres', Ministry of Health, and College of Medicine of Blantyre Collaborative Project.
    Int J Gynecol Cancer. 2021 Jun 2. pii: ijgc-2021-002743.
    PubMed    


  97. NASIOUDIS D, Latif NA, Giuntoli Ii RL, Haggerty AF, et al
    Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors.
    Int J Gynecol Cancer. 2021;31:829-834.
    PubMed     Abstract available


    May 2021
  98. MANZOUR N, Vazquez-Vicente D, Carriles I, Boria F, et al
    Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer.
    Int J Gynecol Cancer. 2021 May 24. pii: ijgc-2021-002592.
    PubMed    


  99. MATSUO K, Nusbaum DJ, Matsuzaki S, Klar M, et al
    Utilization and outcomes of adjuvant systemic chemotherapy alone in high risk, early stage cervical cancer in the United States.
    Int J Gynecol Cancer. 2021 May 20. pii: ijgc-2021-002655.
    PubMed     Abstract available


  100. KUMAR D, Miriyala R, Rai B, Bansal P, et al
    Impact of three-dimensional chemoradiation on pelvic bone mineral density, low back pain, and disability in cervical cancer: a prospective study.
    Int J Gynecol Cancer. 2021 May 11. pii: ijgc-2020-002290.
    PubMed     Abstract available


  101. WRIGHT JD
    Minimal risk for minimally invasive hysterectomy for stage IA cervical cancer?
    Int J Gynecol Cancer. 2021 May 10. pii: ijgc-2021-002733.
    PubMed    


  102. GOMEZ RODRIGO S, Calderon J, Dionisi JN, Santi A, et al
    Cervical cancer in pregnancy at various gestational ages.
    Int J Gynecol Cancer. 2021;31:784-788.
    PubMed    


  103. NAVARRO AS, Angeles MA, Migliorelli F, Illac C, et al
    Comparison of SPECT-CT with intraoperative mapping in cervical and uterine malignancies.
    Int J Gynecol Cancer. 2021;31:679-685.
    PubMed     Abstract available


  104. MUALLEM MZ, Miranda A, Muallem J
    Nerve-sparing radical hysterectomy-Muallem technique with explanation of parametrium and paracolpium anatomy.
    Int J Gynecol Cancer. 2021;31:795-796.
    PubMed    


    April 2021
  105. MAENE C, Salihi RR, Van Nieuwenhuysen E, Han SN, et al
    Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB-IIB cervical cancer.
    Int J Gynecol Cancer. 2021 Apr 15. pii: ijgc-2021-002432.
    PubMed     Abstract available


  106. CORINTI M, Alvarenga-Bezerra V, Ribeiro R, Liao AW, et al
    Extraperitoneal laparoscopic pelvic lymphadenectomy for cervical cancer staging in twin pregnancy.
    Int J Gynecol Cancer. 2021 Apr 13. pii: ijgc-2021-002410.
    PubMed    


  107. CHEN JH, Duan H, Yu XB, Zhao HW, et al
    Clinical features and prognostic factors of cervical villoglandular adenocarcinoma.
    Int J Gynecol Cancer. 2021;31:512-517.
    PubMed     Abstract available


    March 2021
  108. CIBULA D
    Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer.
    Int J Gynecol Cancer. 2021 Mar 18. pii: ijgc-2021-002510.
    PubMed    


  109. SORMANI J, Datchoua AM, Petignat P, Kenfack B, et al
    Effects of the COVID-19 pandemic on an urban cervical cancer screening program in West Cameroon.
    Int J Gynecol Cancer. 2021 Mar 12. pii: ijgc-2021-002555.
    PubMed    


  110. FURUSAWA A, Takekuma M, Mori K, Usami T, et al
    A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
    Int J Gynecol Cancer. 2021 Mar 4. pii: ijgc-2020-002344.
    PubMed     Abstract available


  111. LOPEZ A, Rodriguez J, Estrada E, Aragona A, et al
    Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a Latin-American multicenter study.
    Int J Gynecol Cancer. 2021;31:468-474.
    PubMed     Abstract available


  112. MARTINELLI F, Ditto A, Filippi F, Vinti D, et al
    Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer.
    Int J Gynecol Cancer. 2021;31:457-461.
    PubMed     Abstract available


  113. FANFANI F, Pedone Anchora L, Di Martino G, Bizzarri N, et al
    Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer.
    Int J Gynecol Cancer. 2021;31:452-456.
    PubMed     Abstract available


  114. NICA A, Marchocki Z, Gien LT, Kupets R, et al
    Cervical conization and lymph node assessment for early stage low-risk cervical cancer.
    Int J Gynecol Cancer. 2021;31:447-451.
    PubMed     Abstract available


  115. NOLL F, Palacios Torres AT, Pecci P, Lucchini SM, et al
    Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
    Int J Gynecol Cancer. 2021;31:379-386.
    PubMed     Abstract available


  116. BUONOMO B, Multinu F, Casarin J, Betella I, et al
    Ovarian transposition in patients with cervical cancer prior to pelvic radiotherapy: a systematic review.
    Int J Gynecol Cancer. 2021;31:360-370.
    PubMed     Abstract available


  117. DOGAN NU, Kohler C, Pfiffer T, Plaikner A, et al
    Prospective assessment of urinary and bowel symptoms, and sexual function between laparoscopic assisted vaginal radical trachelectomy and radical hysterectomy.
    Int J Gynecol Cancer. 2021;31:484-489.
    PubMed     Abstract available


  118. BAIOCCHI G, Vieira M, Moretti-Marques R, Mantoan H, et al
    Uterine transposition for gynecological cancers.
    Int J Gynecol Cancer. 2021;31:442-446.
    PubMed     Abstract available


  119. BURBANO J, Heredia F, Sanabria D, Ardila EG, et al
    Neoadjuvant chemotherapy prior to fertility-sparing surgery in cervical tumors larger than 2 cm: a systematic review on fertility and oncologic outcomes.
    Int J Gynecol Cancer. 2021;31:387-398.
    PubMed     Abstract available


  120. STEWART K, Campbell S, Frumovitz M, Ramirez PT, et al
    Fertility considerations prior to conservative management of gynecologic cancers.
    Int J Gynecol Cancer. 2021;31:339-344.
    PubMed     Abstract available


  121. MORO F, Bonanno GM, Gui B, Scambia G, et al
    Imaging modalities in fertility preservation in patients with gynecologic cancers.
    Int J Gynecol Cancer. 2021;31:323-331.
    PubMed     Abstract available


    February 2021
  122. CAMPITELLI M, Lazzari R, Piccolo F, Ferrazza P, et al
    Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review.
    Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2020-002310.
    PubMed     Abstract available


  123. MCCORMACK M, Gaffney D, Tan D, Bennet K, et al
    The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries.
    Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2021-002422.
    PubMed     Abstract available


  124. SCOTT AA, Yarney J, Vanderpuye V, Akoto Aidoo C, et al
    Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.
    Int J Gynecol Cancer. 2021 Feb 8. pii: ijgc-2020-002120.
    PubMed     Abstract available


  125. STOLNICU S, Boros M, Hoang L, Almadani N, et al
    FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
    Int J Gynecol Cancer. 2021;31:177-184.
    PubMed     Abstract available


    January 2021
  126. RODRIGUEZ J, Rauh-Hain JA, Saenz J, Isla DO, et al
    Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis.
    Int J Gynecol Cancer. 2021 Jan 27. pii: ijgc-2020-002086.
    PubMed     Abstract available


  127. LI L, Wu M
    Pelvic nerves during radical trachelectomy.
    Int J Gynecol Cancer. 2021;31:154.
    PubMed    


  128. SAKURAGI N, Kaneuchi M
    Paracervical and paravaginal tissue dissection in the Okabayashi-Kobayashi radical hysterectomy and nerve-sparing technique.
    Int J Gynecol Cancer. 2021;31:145-146.
    PubMed    


    December 2020
  129. CAO L, Wen H, Feng Z, Han X, et al
    Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
    Int J Gynecol Cancer. 2020 Dec 10. pii: ijgc-2020-001974.
    PubMed     Abstract available


  130. KIM N, Choi SH, Chang JS, Kim YT, et al
    Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer.
    Int J Gynecol Cancer. 2020 Dec 3. pii: ijgc-2020-002031.
    PubMed     Abstract available


  131. MARNITZ S, Tsunoda AT, Martus P, Vieira M, et al
    Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Int J Gynecol Cancer. 2020;30:1855-1861.
    PubMed     Abstract available


    November 2020
  132. RENDON GJ, Lopez Blanco A, Aragona A, Saadi JM, et al
    Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer >/=2 cm.
    Int J Gynecol Cancer. 2020 Nov 16. pii: ijgc-2020-002076.
    PubMed     Abstract available


  133. OLTHOF EP, Mom CH, van der Velden J
    More attention is needed for the corrigendum to the revised FIGO staging for carcinoma of the cervix uteri.
    Int J Gynecol Cancer. 2020;30:1850.
    PubMed    


    October 2020
  134. SANTORO A, Angelico G, Inzani F, Arciuolo D, et al
    Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 30. pii: ijgc-2020-001710.
    PubMed     Abstract available


  135. SMALL W JR, Peltecu G, Puiu A, Corha A, et al
    Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference.
    Int J Gynecol Cancer. 2020 Oct 29. pii: ijgc-2020-001652.
    PubMed     Abstract available


  136. PRECI DP, Almeida A, Weiler AL, Mukai Franciosi ML, et al
    Oxidative damage and antioxidants in cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 27. pii: ijgc-2020-001587.
    PubMed     Abstract available


  137. ALLANSON ER, Velanova V, Frazer IH, McAdam M, et al
    An update on cervical cancer screening in Vanuatu.
    Int J Gynecol Cancer. 2020 Oct 26. pii: ijgc-2020-002129.
    PubMed    


  138. LIN F, Zheng R, Yu C, Su Y, et al
    Predictive role of serum cholesterol and triglycerides in cervical cancer survival.
    Int J Gynecol Cancer. 2020 Oct 13. pii: ijgc-2020-001333.
    PubMed     Abstract available


  139. BERCOW AS, Nitecki R, Haber H, Gockley AA, et al
    Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 12. pii: ijgc-2020-001812.
    PubMed     Abstract available


  140. NICA A, Kim SR, Gien LT, Covens A, et al
    Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?
    Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001816.
    PubMed     Abstract available


  141. ANDERSEN B, Njor SH, Jensen AMS, Johansen T, et al
    HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study.
    Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001457.
    PubMed     Abstract available


  142. HARRISON R, Ramirez PT
    Bronchocutaneous fistula from metastatic cervical cancer with COVID-19.
    Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001976.
    PubMed    


  143. DE CUYPERE M, Lovinfosse P, Gennigens C, Hermesse J, et al
    Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020 Oct 8. pii: ijgc-2020-001676.
    PubMed     Abstract available


    September 2020
  144. GOVOROV I, Dikareva E, Velichko E, Kesic V, et al
    Human-machine alliance against cervical cancer.
    Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-002064.
    PubMed    


  145. GULTEKIN M, Beduk Esen CS, Balci B, Alanyali S, et al
    Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
    Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-001733.
    PubMed     Abstract available


  146. NAGASE Y, Kobayashi E, Takiuchi T, Kodama M, et al
    Challenges of laparoscopic lymphadenectomy for cervical cancer in pregnant women: techniques and tips.
    Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-001703.
    PubMed    


  147. TU H, Huang H, Xian B, Li J, et al
    Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010).
    Int J Gynecol Cancer. 2020 Sep 24. pii: ijgc-2020-001857.
    PubMed     Abstract available


    May 2020
  148. VAZQUEZ-VICENTE D, Castellanos T, Cabello A, Chacon E, et al
    Multidisciplinary approach in the pelvic relapse of a previously irradiated cervical tumor.
    Int J Gynecol Cancer. 2020;30:714.
    PubMed    


  149. GULTEKIN M, Turan SH, Boztas G, Ozturk C, et al
    Passion for saving lives: Turkey between 2012 and 2017.
    Int J Gynecol Cancer. 2020;30:709-710.
    PubMed    


  150. PAREJA R
    Safety of minimally invasive radical hysterectomy in cervical tumors <2 cm.
    Int J Gynecol Cancer. 2020;30:572-574.
    PubMed    


    April 2020
  151. CHAMBERS LM, Herrmann A, Michener CM, Ferrando CA, et al
    Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma.
    Int J Gynecol Cancer. 2020;30:515-524.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: